Use of an antispasmodic (rociverine) to shorten the length of labor: A randomized, placebo-controlled trial

Acta Obstetricia et Gynecologica Scandinavica

Volumn 90, Issue 12, 2011, Pages 1371-1378

  Cromi, Antonella ^a   Ghezzi, Fabio ^a   Agosti, Massimo ^b   Uccella, Stefano ^a   Piazza, Nicoletta ^a   Serati, Maurizio ^a   Bolis, Pierfrancesco ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b Ospedale F del Ponte   (Italy)

Author keywords

Antispasmodic; cervical dilatation rate; duration of labor; first stage; labor management; spasmolytic

Indexed keywords

OXYTOCIN; PLACEBO; ROCIVERINE;

ABSENCE OF SIDE EFFECTS; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD PH; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HORMONAL THERAPY; HUMAN; LABOR INDUCTION; LABOR STAGE 1; LABOR STAGE 2; MAJOR CLINICAL STUDY; NULLIPARA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME; UMBILICAL ARTERY; UTERINE CERVIX DILATATION; UTERINE CERVIX RIPENING;

ADULT; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; LABOR STAGE, FIRST; PARASYMPATHOLYTICS; PARITY; PREGNANCY; TIME FACTORS;

EID: 81355124867     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01265.x     Document Type: Article

References (28)

1. Cheng YW, Shaffer BL, Bryant AS, Caughey AB,. Length of the first stage of labor and associated perinatal outcomes in nulliparous women. Obstet Gynecol. 2010; 116: 1127-35.
2. Waldenstrom U, Borg IM, Olsson B, Skold M, Wall S,. The childbirth experience: a study of 295 new mothers. Birth. 1996; 23: 144-53. (Pubitemid 126443525)
3. Wei S, Wo BL, Xu H, Luo ZC, Roy C, Fraser WD,. Early amniotomy and early oxytocin for prevention of, or therapy for, delay in first stage spontaneous labour compared with routine care. Cochrane Database Syst Rev. 2009;(2): CD006794.
4. Hirsch FE,. Anti-spasmodic drugs in labour. Br Med J. 1937; 2: 559-60.
5. Clark BB, Shires EBS,. The action of Syntropan on the uterus. J Pharmacol Exp Ther. 1940; 70: 378-87.
6. Leuxner E, Thomas J,. Clinical results with the spasmolytic buscopan in obstetrics. Munch Med Wochenschr. 1952; 94: 564-7.
7. Chan DPC,. The use of Buscopan during the first stage of labor. Hong Kong Med Ass CME Bull. 1963; 15: 69-71.
8. Guerresi E, Gori G, Beccari A, Farro M, Mazzanti C,. Influence of spasmolytic treatment and amniotomy on delivery times: a factorial clinical trial. Clin Ther. 1981; 3: 382-8. (Pubitemid 11110547)
9. Sharma JB, Pundir P, Kumar A, Murthy NS,. Drotaverine hydrochloride vs. valethamate bromide in acceleration of labor. Int J Gynaecol Obstet. 2001; 74: 255-60. (Pubitemid 32785660)
10. Singh KC, Jain P, Goel N, Saxena A,. Drotaverine hydrochloride for augmentation of labor. Int J Gynaecol Obstet. 2004; 84: 17-22. (Pubitemid 38064138)
11. Tabassum S, Afridi B, Aman Z,. Phloroglucinol for acceleration of labour: double blind, randomized controlled trial. J Pak Med Assoc. 2005; 55: 270-3. (Pubitemid 41787443)
12. Sirohiwal D, Dahiya K, De M,. Efficacy of hyoscine-N-butyl bromide (Buscopan) suppositories as a cervical spasmolytic agent in labour. Aust N Z J Obstet Gynaecol. 2005; 45: 128-9. (Pubitemid 40528556)
13. Samuels LA, Christie L, Roberts-Gittens B, Fletcher H, Frederick J,. The effect of hyoscine butylbromide on the first stage of labour in term pregnancies. BJOG. 2007; 114: 1542-6. (Pubitemid 350077425)
14. Roy A, Patra KK, Mukhopadhyay S, Guha S,. Study of drotaverine on first stage of labour and pregnancy outcome. J Indian Med Assoc. 2007; 105: 450, 452.
15. Gupta B, Nellore V, Mittal S,. Drotaverine hydrochloride versus hyoscine-N-butylbromide in augmentation of labor. Int J Gynaecol Obstet. 2008; 100: 244-7. (Pubitemid 351258093)
16. Aggarwal P, Zutshi V, Batra S,. Role of hyoscine N-butyl bromide (HBB, buscopan®) as labor analgesic. Indian J Med Sci. 2008; 62: 179-84. (Pubitemid 351821548)
17. Yilmaz B, Kart C, Kelekci S, Gokturk U, Sut N, Tarlan N, et al,. Meperidine versus valethamate bromide in shortening the duration of active labor. Int J Gynaecol Obstet. 2009; 107: 126-9.
18. Madhu C, Mahavarkar S, Bhave S,. A randomised controlled study comparing Drotaverine hydrochloride and Valethamate bromide in the augmentation of labour. Arch Gynecol Obstet. 2010; 282: 11-5.
19. Available at: (accessed 19 September 2011).
20. Barbier P, Renzetti AR, Turbanti L, Di Bugno C, Fornai F, Vaglini F, et al,. Stereoselective inhibition of muscarinic receptor subtypes by the eight stereoisomers related to rociverine. Eur J Pharmacol. 1995; 290: 125-32.
21. D'Agostino G, Zonta F, Santagostino Barbone MG, Grana E, Brunori P, Subissi A,. Mechanism of smooth muscle relaxation by rociverine. Arzneimittelforschung. 1984; 34: 584-9. (Pubitemid 14145551)
22. Faul F, Erdfelder E, Lang A-G, Buchner A,. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007; 39: 175-91.
23. Bulat R, Kannan MS, Garfield RE,. Studies of the innervation of rabbit myometrium and cervix. Can J Physiol Pharmacol. 1989; 67: 837-44. (Pubitemid 19276557)
24. Sato S, Hayashi RH, Garfield RE,. Mechanical responses of the rat uterus, cervix, and bladder to stimulation of hypogastric and pelvic nerves in vivo. Biol Reprod. 1989; 40: 209-19.
25. Morizaki N, Morizaki J, Hayashi RH, Garfield RE,. A functional and structural study of the innervation of the human uterus. Am J Obstet Gynecol. 1989; 160: 218-28. (Pubitemid 19055296)
26. Tingaker BK, Irestedt L,. Changes in uterine innervation in pregnancy and during labour. Curr Opin Anaesthesiol. 2010; 23: 300-3.
27. Bryman I, Norström A, Lindblom B,. Influence of prostaglandins and adrenoceptor agonists on contractile activity in the human cervix at term. Obstet Gynecol. 1986; 67: 574-8. (Pubitemid 16116280)
28. Impey L,. Maternal attitudes to amniotomy and labor duration: a survey in early pregnancy. Birth. 1999; 26: 211-4.